CD4 and tuberculosis: Seven-day treatment of MC38 TB mice with ceralasertib caused a marked decrease in the presence of all populations of T-cell precursors in the thymus (Supplementary Fig. 7A), as well as all populations of CD4/CD8 double negative (DN) cells (Supplementary Fig. 7B).